Lopez-Miranda Beatriz MD is categorized under Internal Medicine Doctors in Houston, TX and active since 2011.
Lopez-Miranda Beatriz MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Beatriz Lopez-Miranda at the company’s single location by writing to 2727 West Holcombe Boulevard, Houston, Texas TX 77025 or by phoning (713) 442-0000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lopez-Miranda Beatriz MD |
| Contact Person: | Beatriz Lopez-Miranda |
| Address: | 2727 West Holcombe Boulevard, Houston, Texas 77025 |
| Phone Number: | (713) 442-0000 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Lopez-Miranda Beatriz MD was started in 2011 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Beatriz Lopez-Miranda for inquiries that concern Lopez-Miranda Beatriz MD by calling the company number (713) 442-0000, as your correspondence is most welcome. Additionally, the physical location of the single location of Lopez-Miranda Beatriz MD can be found at the coordinates 29.70601,-95.42143 as well as the street address 2727 West Holcombe Boulevard in Houston, Texas 77025.
For its online presence, you may visit Lopez-Miranda Beatriz MD’s website at and engage with its social media outlets through on Twitter and on Facebook.